REDWOOD SHORES, CA – February 10, 2016 – Boosting clinical development productivity and efficiency is a top priority for life sciences organizations. To that end, Oracle today announced that two of its core Health Sciences offerings - Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics - have been selected by Bayer HealthCare, to oversee and manage the company’s clinical monitoring processes. Bayer HealthCare, a subgroup of Bayer AG researches, develops, manufactures, and markets pharmaceutical and medical products.
Oracle’s life sciences-specific solutions, combined with its broader product and service offering, are used by thousands of pharma, biopharma, and academic research centers worldwide to redesign clinical R&D processes, advance drug therapies, and optimize care delivery to improve the health, well-being, and lives of people globally.
“Oracle Health Sciences is committed to helping organizations, such as Bayer HealthCare, advance its vision of innovation to drive faster, safer, and more cost-effective therapies and treatments to improve lives around the globe,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Our proven solutions are helping industry leaders, as well as emerging organizations, power innovation across the clinical development lifecycle.”
Oracle Siebel Clinical Trial Management System manages and monitors clinical testing sites for any issues as they arise. Oracle Health Sciences Clinical Development Analytics provides an effective platform that optimizes actionable, clinical analytics, addresses compliance issues, and monitors resources. Together, these solutions give clinical research associates greater visibility into site performance, with the ability to track open issues to resolution and manage risk.
Oracle Health Sciences’ advanced clinical trial solutions for data collection, management, and analysis help optimize research, mitigate risk, monitor/report adverse events, and drive medical insight for precision medicine
Additional Information
To learn more about Oracle Health Sciences, please follow @OracleHealthSci and Oracle Health Sciences.
About Oracle
Oracle offers a comprehensive and fully integrated stack of cloud applications and platform services. For more information about Oracle (NYSE:ORCL), visit oracle.com.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.